Blood-Based Kinase Assessments in Alzheimer’s Disease
Alzheimer’s disease (AD) is marked by memory disturbances followed by aphasia, apraxia and agnosia. Brain lesions include the accumulation of the amyloid peptide in extracellular plaques, neurofibrillary tangles with abnormally phosphorylated tau protein and synaptic and neuronal loss. New findings...
Main Authors: | Jacques Hugon, François Mouton-Liger, Emmanuel Cognat, Julien Dumurgier, Claire Paquet |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-11-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnagi.2018.00338/full |
Similar Items
-
PKR involvement in Alzheimer’s disease
by: Jacques Hugon, et al.
Published: (2017-10-01) -
Are ketogenic diets promising for Alzheimer’s disease? A translational review
by: Matthieu Lilamand, et al.
Published: (2020-04-01) -
CSF levels of the BACE1 substrate NRG1 correlate with cognition in Alzheimer’s disease
by: François Mouton-Liger, et al.
Published: (2020-07-01) -
Pro-apoptotic kinases levels in cerebrospinal fluid as potential future biomarkers in Alzheimer’s Disease
by: Claire ePAQUET, et al.
Published: (2015-08-01) -
Inverse association between CSF Aβ 42 levels and years of education in mild form of Alzheimer's disease: The cognitive reserve theory
by: Julien Dumurgier, et al.
Published: (2010-11-01)